<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">toxreview</journal-id><journal-title-group><journal-title xml:lang="ru">Токсикологический вестник</journal-title><trans-title-group xml:lang="en"><trans-title>Toxicological Review</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">0869-7922</issn><issn pub-type="epub">3034-4611</issn><publisher><publisher-name>Federal Scientific Center of Hygiene named after F.F. Erisman</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">toxreview-453</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Статьи</subject></subj-group></article-categories><title-group><article-title>КОРРЕКЦИЯ ПРЕПАРАТОМ «ТАУЦИН» ПОКАЗАТЕЛЕЙ ГЕПАТОТОКСИЧНОСТИ В ПЛАЗМЕ КРЫС С ХОЛЕСТАЗОМ»</article-title><trans-title-group xml:lang="en"><trans-title>CORRECTION WITH «TAUCINE» OF HEPATOTOXICITY PARAMETERS IN PLASMA OF RATS WITH CHOLESTASIS</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Пашко</surname><given-names>Анастасия Юрьевна</given-names></name><name name-style="western" xml:lang="en"><surname>Pashko</surname><given-names>Anastasiya Urjevna</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ассистент и аспирант кафедры фармакологии им. профессора М.В. Кораблева УО «Гродненский государственный медицинский университет» МЗ Республики Беларусь, 230005, г. Гродно, Республика Беларусь</p><p>e-mail: anfstas@inbox.ru </p></bio><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бушма</surname><given-names>Кирилл Михайлович</given-names></name><name name-style="western" xml:lang="en"><surname>Bushma</surname><given-names>Kiryll Mikhailovich</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кандидат медицинских наук, доцент кафедры анестезиологии и реаниматологии, 230017, г. Гродно, Республика Беларусь </p></bio><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Борисенок</surname><given-names>Ольга Александровна</given-names></name><name name-style="western" xml:lang="en"><surname>Borisenok</surname><given-names>Olga Alexandrovna</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кндидат медицинских наук, ассистент кафедры фармакологии им. профессора М.В. Кораблева УО «Гродненский государственный медицинский университет» МЗ Республики Беларусь, 230005, г. Гродно, Республика Беларусь</p></bio><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бушма</surname><given-names>Михаил Иванович</given-names></name><name name-style="western" xml:lang="en"><surname>Bushma</surname><given-names>Mihail Ivanovich</given-names></name></name-alternatives><bio xml:lang="ru"><p>Доктор медицинских наук, профессор кафедры фармакологии им. профессора М.В. Кораблева УО«Гродненский  государственный медицинский университет» МЗ Республики Беларусь, 230005, г. Гродно, Республика Беларусь</p><p>e-mail: pharma@grsmu.by </p></bio><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>УО «Гродненский государственный медицинский университет» МЗ Республики Беларусь, кафедра фармакологии им. профессора М.В. Кораблева</institution><country>Беларусь</country></aff><aff xml:lang="en"><institution>Educational Institution «Grodno State Medical University» M.V. Korablev Chair of Pharmacology, Ministry of Health of the&#13;
Republic of Belarus</institution><country>Belarus</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>УО «Гродненский государственный медицинский университет» МЗ Республики Беларусь, кафедра анестезиологии и реаниматологии</institution><country>Беларусь</country></aff><aff xml:lang="en"><institution>Educational Institution «Grodno State Medical University»; Chair of Anaesthesiology and Intensive Care , Ministry of Health of the Republic of Belarus</institution><country>Belarus</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2015</year></pub-date><pub-date pub-type="epub"><day>12</day><month>08</month><year>2021</year></pub-date><volume>0</volume><issue>3</issue><fpage>12</fpage><lpage>15</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Пашко А.Ю., Бушма К.М., Борисенок О.А., Бушма М.И., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Пашко А.Ю., Бушма К.М., Борисенок О.А., Бушма М.И.</copyright-holder><copyright-holder xml:lang="en">Pashko A.U., Bushma K.M., Borisenok O.A., Bushma M.I.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.toxreview.ru/jour/article/view/453">https://www.toxreview.ru/jour/article/view/453</self-uri><abstract><p>У крыс с холестатическим поражением печени (перевязка общего желчного протока в течение 13 дней) комбинация таурина с цинка диаспартатом в соотношении компонентов 50 г/молей: 1 г/молю («тауцин-50») в дозе 0,5 г/кг обладает гепатозащитным действием, судя по улучшению маркерных биохимических показателей гепатотоксичности в плазме. По мере увеличения периода холестаза до 21 дня и нарастания степени тяжести гепатопатии, «тауцин-20» в вышеуказанной дозе также обладает равноэффективным гепатозащитным действием.</p></abstract><trans-abstract xml:lang="en"><p>In rats with liver cholestatic injury ( common bile duct ligation during 13 days), a combination of taurine with zinc diaspartate in the ratio of 50 g/mole to 1 g/mole. («taucine-50») in dose of 0.5 g/kg shows a hepatoprotective effect judging from improvement of marker biochemical indicators of hepatotoxicity in plasma. As the period of cholesterase increases up to 21 days and hepatopathy is worsenig, «taucine-20» in the above mentioned dose also produces an equivalent hepatoprotective effect.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>крысы</kwd><kwd>холестаз</kwd><kwd>маркерные биохимические показатели гепатотоксичности в плазме</kwd><kwd>комбинация таурина с цинка диаспартатом</kwd><kwd>гепатозащитное действие</kwd></kwd-group><kwd-group xml:lang="en"><kwd>rats</kwd><kwd>cholestasia</kwd><kwd>marker biochemical indicators of hepatotoxicity in plasma</kwd><kwd>combination of taurine with zinc diaspartate</kwd><kwd>hepatoprotective action</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Машковский М.Д. Лекарственные средства. Москва: Новая волна; 2005.</mixed-citation><mixed-citation xml:lang="en">Mashkovskij M.D. Drugs. Moskva: Novaja volna; 2005 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Бут-Гусаим Л.Ст., Геращенко Н.В., Блошко Т.Е. Перспективы использования препаратов цинка в перинатологии. Материалы научнопрактической конференции посвященной 60 лет службе скорой помощи и 10 лет УЗ «ГКО СМП». 5-7 сентября 2005. Гродно: ГрГМУ; 2005.</mixed-citation><mixed-citation xml:lang="en">But-Gusaim L.St., Gerashchenko N.V., Bloshko T.E. Prospects of use of preparations of zinc in a perinatologi. Materialy nauchnoprakticheskoy konferentsii posvyashchennoy 60 let sluzhbe skoroy pomoshchi i 10 let UZ «GKO SMP». 5-7 sentyabrya 2005. Grodno: GrGMU; 2005 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Truong-Tran A.Q. et al. The role of zinc in caspase activation and apoptotic cell death. Biometals. 2001; 14: 315–330.</mixed-citation><mixed-citation xml:lang="en">Truong-Tran A.Q. et al. The role of zinc in caspase activation and apoptotic cell death. Biometals. 2001; 14:315-330.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Schumann G. et al. IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37 degrees C. Part 3. Reference procedure for the measurement of catalytic concentration of lactate dehydrogenase. Clin. Chem. Lab. Med. 2002; 40: 643-648.</mixed-citation><mixed-citation xml:lang="en">Schumann G. et al. IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37 degrees C. Part 3. Reference procedure for the measurement of catalytic concentration of lactate dehydrogenase. Clin. Chem. Lab. Med. 2002; 40: 643-648.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Гаврилов В.Б., Мишкорудная М.И. Спектрофотометрическое определение содержания гидроперекисей липидов в плазме крови. Лабораторное дело. 1983; 3: 33-36.</mixed-citation><mixed-citation xml:lang="en">Gavrilov V.B., Mishkorudnaya M.I. Spectrophotometric determination of lipid hydroperoxide content in the plasma of blood. Laboratornoye delo. 1983; 3: 33-36 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Камышников В.С. Справочник по клинико-биохимической лабораторной диагностике T. 2. Минск: «Беларусь»; 2002.</mixed-citation><mixed-citation xml:lang="en">Kamyshnikov V.S. Handbook of clinical and biochemical laboratory diagnosis T. 2. Minsk: «Belarus’»; 2002 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Реброва О.Ю. Статистический анализ медицинских данных. Москва: МедиаСфера; 2002.</mixed-citation><mixed-citation xml:lang="en">Rebrova O.Yu. Statistical analysis of medical data. Moskva: MediaSfera; 2002 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Stiehi A. Disturbances of bile acid metabolism on cholestasis. Clin. Gastroenterol. 1977; 6: 35-67.</mixed-citation><mixed-citation xml:lang="en">Stiehi A. Disturbances of bile acid metabolism on cholestasis. Clin. Gastroenterol. 1977; 6: 35-67.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Harada H. et al. Oral taurine supplementation prevents the development of ethanol-induced hypertension in rats. Hypertens Res. 2000; 23: 277–284.</mixed-citation><mixed-citation xml:lang="en">Harada H. et al. Oral taurine supplementation prevents the development of ethanol-induced hypertension in rats. Hypertens Res. 2000; 23: 277-284.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Formigari A., Irato P., Santon A. Zinc, antioxidant systems and metallothionein in metal mediated-apoptosis: biochemical and cytochemical aspects. Comp. Biochem. Physiol. Pt. C. 2007; 146: 443–459</mixed-citation><mixed-citation xml:lang="en">Formigari A., Irato P., Santon A. Zinc, antioxidant systems and metallothionein in metal mediated-apoptosis: biochemical and cytochemical aspects. Comp. Biochem. Physiol. Pt. C. 2007; 146: 443-459.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
